Haemonetics (HAE) Acquisitions (2010 - 2026)

Haemonetics has reported Acquisitions for 10 years, with the latest figure at $60.2 million in Q1 2026.

• On a quarterly basis, Acquisitions changed N/A year-over-year to $60.2 million in Q1 2026; TTM through Mar 2026 was $60.2 million, a 60.12% decrease from a year earlier, with the FY2026 full-year figure at $60.2 million, down 60.12% from the prior year.
• Acquisitions was $60.2 million for Q1 2026 at Haemonetics, up from $1.8 million in the prior quarter.
• The five-year high for Acquisitions was $243.9 million in Q4 2023, with the low at $1.8 million in Q3 2024.
• Average Acquisitions over 4 years is $91.6 million, with a median of $60.2 million recorded in 2026.
• The largest YoY upside for Acquisitions was 14.0% in 2022 against a maximum downside of 14.0% in 2022.
• Over 4 years, Acquisitions stood at $2.8 million in 2022, then jumped by 8456.21% to $243.9 million in 2023, then sank by 99.28% to $1.8 million in 2024, then jumped by 3329.06% to $60.2 million in 2026.
• The last three Acquisitions figures came in at $60.2 million (Q1 2026), $1.8 million (Q3 2024), and $149.2 million (Q2 2024), per Business Quant data.